Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


15 11, 2010

England Makes Tough Decisions About Which Multiple Myeloma/Cancer Drugs To Allow

Tags: , , , , |2 Comments

Here is an in-depth, candid look at the English system of state controlled health care, where recommendations from a group of English physicians and medical experts known as NICE sometimes limits patient access to some drugs the group deems ineffective or too expensive.For example, NICE allows use of Thalomid or Velcade, but not Revlimid in

5 09, 2010

Another Example Of How High Cost Of Anti-Myeloma Chemotherapy Drugs May Restrict Patient Accsess

Tags: , , , , , |0 Comments

Last week I passed along a surprising and disappointing report about how the use of Revlimid was possibly going to be restricted in the UK. Here is a follow-up article, listing thalidomide as the approved alternative. Why? Cost of course! Guess they don't care if British multiple myeloma patients limp around with peripheral neuropathy--as long